Algorithm for the treatment of calcinosis #calcinosis @RheumNow #ACR24 https://t.co/NZhP7Enzrp https://t.co/1mO8waM5DI

• https://buff.ly/4j2TK7A

Best of 2024: Eating for Rheumatoid Arthritis https://t.co/gtK3F6FdEB https://t.co/ILA6lSohh7

• Best of 2024: Eating for Rheumatoid Arthritis | RheumNow

Best of 2024: Mixed Long-term Effects of Calcium and Vitamin D in Postmenopausal Women https://t.co/rFOW4OpZS7 https://t.co/A0EN8b9KYB

• Best of 2024: Mixed Long-term Effects of Calcium and Vitamin D in Postmenopausa…

Small but useful open label RCT of MMF vs CYC vs TAC in SLE nephritis Surprisingly similar rates of remission at week 24... suggests TAC could be an option for induction? #ACR24 @RheumNow Abstr#0670 https://t.co/dr3M3cnjRG https://t.co/1wewEuJRAl

• https://buff.ly/40dfIx0

Overview of Uveitis management of adult & pediatric rheumatology. - Uveitis accounts for 10% of visual impairment globally - TNF inhib are effective; w/ IL-6 inhib as 2nd line options https://t.co/fwhTxEpVG0 https://t.co/cKGdcDbz3d

• The management of adult and paediatric uveitis for rheumatologists

A cohort of 9 patients with Anti-MDA5 DM with RPILD who was treated with combination of RTX, JAKi, and GCS had significantly bettery survival compared to historical cohort in this abstract! #ACR24 @RheumNow https://t.co/PMVn5Pb1b3

• https://buff.ly/40hlei4

Best of 2024: SGLT2 Inhibitor Protective Effects in Lupus https://t.co/zLxEOnWjpB https://t.co/I8jBcxO6rH

• Best of 2024: SGLT2 Inhibitor Protective Effects in Lupus | RheumNow

Best of 2024: Good Clinical Practice Recommendations on Glucocorticoid Withdrawal and Adrenal Insufficiency https://t.co/atoMR1YChT https://t.co/OeaF9QUGEz

• Best of 2024: Good Clinical Practice Recommendations on Glucocorticoid Withdraw…

Full read JAMA ILD Review article. ILD= 33% idiopathic (IPF) + 15% hypersensitivity pneumonitis + 25% from CTD. 30% of ILD has cough Chest CT 91% sensitive, 71% specific 5% decr in FVC/12 mos assoc w/ 2-fold incr in mortality Rx options nintedanib or pirfenidone, TCZ, MMF, RTX… https://t.co/FKZyNU1s06 https://t.co/w5q0hOesEH

What is Osteoarthritis? A downloadable patient education page from JAMA. https://t.co/PfoimFgxRp https://t.co/WVQbofTzGC

• Patient Information: Knee Osteoarthritis

171 SSc pts w/ hand Xrays and US found 20% w/ Joint involvement. Active Synovitis & tenosynovitis predicted by CRP>10mg/L (p = 0.013), fibrotic tenosynovitis on US (p = 0.005), anti-RNA polymerase III antibodies (p = 0.043) https://t.co/XYeMl6ag9c https://t.co/ycM573lUGT

• Combined radiographic and ultrasound evaluations to decipher joint involvement …

FDA has approved Eli Lilly’s GLP-1 drug Zepbound [tirzepatide] to treat moderate to severe obstructive sleep apnea in adults with obesity in combination with increased physical activity and a reduced-calorie diet.” https://t.co/rYiM6JzmDX https://t.co/hO6CgH9pVs

• Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for slee…

12 minute JAMA Podcast on Dx & Rx of Lupus - featuring Caroline H. Siegel, MD, from HSS in NYC. https://t.co/4iHdQTFxxw https://t.co/zrNsartPlq

• Diagnosis and Treatment of Systemic Lupus Erythematosus